ALERT: COVID19 Update: For your safety, you will be asked to use a mask, if you do not have one, a mask will be provided. If a person presents with a temperature, you will be asked to return home and further instructions will be given by your health care team. For our patient’s protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. Telemedicine visits are available for routine office visits.

All Patients – Very Important: Regardless of vaccination status.  If you are experiencing a fever or cold-like like symptoms, which also include GI Symptoms and Diarrhea, you should contact your Virginia Cancer Specialists Advice Line before visiting our clinics for scheduled appointments. This includes symptoms of respiratory illness, such as coughing or difficulty breathing.  More Information-PLEASE CLICK HERE

Alexander I Spira, MD, PhD, FACP - Sotorasib for Lung Cancers with KRAS p.G12C Mutation, The New England Journal of Medicine

Virginia Cancer Specialists Practice Blog

June 04, 2021
Virginia Cancer Specialists » VCS Practice News » Physicians » VCS Practice News » Alex Spira MD PhD FACP » Alexander I Spira, MD, PhD, FACP – Sotorasib for Lung Cancers with KRAS p.G12C Mutation, The New England Journal of Medicine

Congratulations to Alexander I Spira, MD, PhD, FACP for Co-Authoring this important Abstract on Lung Cancer – published in The New England Journal of Medicine.

Click below to view the PDF

Sotorasib for Lung Cancers with KRAS p.G12C Mutation  

thumbnail of NEJM Sotorasib in lung cancer A Spira Absract New England Journal of Medicine


Previous

1 of 1

Next